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OmanAbstract Background and objectives: Adverse drug reaction (ADR) monitoring and reporting
requires a multidisciplinary approach and pharmacists have a major role to play in it. The present
pilot study was conducted to assess the knowledge, attitude and behavior of community pharma-
cists to ADR related aspects in the Sultanate of Oman.
Methods: A self-administered questionnaire comprising of 21 questions were distributed to a
random sample of pharmacists in two Governorates in the Sultanate of Oman. It assessed the
knowledge of pharmacists on some of the selected basic aspects of drug safety. Further, the knowl-
edge and attitude of community pharmacists toward ADR reporting and their behavior on ADR
related aspects were assessed. A scoring scheme was used to estimate the median total score of par-
ticipants for various parameters. Obtained scores were correlated with the demographics of the
respondents.
Results: A total of 107 community pharmacists participated in the survey giving a response rate
of 72.3%. The responses of the pharmacists to the questions on the drug safety of individual drugs
were incorrect for some important and practical questions. Consequently, total median score cor-
responding to these questions was 5 (Inter Quartile Range, IQR 2) out of a possible maximum score
of 9, which was below the acceptable score. Total median score based on knowledge, attitude and
behavior was 38 (IQR 8) out of a possible maximum of 50 which shows a moderate score. Lack of
164 J. Jose et al.awareness on how to report an ADR and concern that the report may be wrong were the most com-
mon factors discouraging pharmacists from reporting ADRs. Qualiﬁcation as well as years of expe-
rience were the only demographic parameters which had an inﬂuence on the score obtained by the
pharmacists.
Conclusions: Even though the pharmacists had an acceptable knowledge, attitude and behavior
on ADR reporting and related aspects, a good number of them had below than acceptable knowl-
edge on drug safety related aspects of speciﬁc drugs. Educational programs have to be continued to
generate awareness on how to report ADR and stimulate pharmacists’ more active participation in
the pharmacovigilance program. There is a genuine need to have training programs to improve the
knowledge of pharmacists on ADR related aspects which are of beneﬁt on a daily basis which could
greatly have an impact on patient safety.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Adverse drug reactions (ADRs) are an important cause of
morbidity and mortality (Lee and Thomas, 2007). ADRs
are both reversible and preventable at many instances,
which increase the importance of early identiﬁcation and
treatment of them. The preventable nature of adverse reac-
tions is the motivation for current ADR reporting programs
(Tsounonis, 2006; Ting et al., 2010). ADR and its related
aspects require a multidisciplinary approach wherein various
health care professionals have to make a signiﬁcant contri-
bution; especially pharmacists. Most often, the pharmacist is
in a unique position to safeguard the patient from prevent-
able ADRs (Tsounonis, 2006). Pharmacist participation can
greatly help overcome underreporting of ADRs (Zolezzi and
Parsotam, 2005; Elkami et al., 2011; Grootheest et al.,
2004). Their role in the education of other healthcare pro-
fessionals about the prevention, detection and reporting of
ADRs is integral.
Community pharmacists have a unique role in monitoring
and reporting of ADRs due to their ease of access for patients
and chances that the patients approach them for the manage-
ment of symptoms associated with ADRs. Further, they have a
major role in preventing ADRs by giving appropriate medica-
tion counseling for the patients. It is important to know the
community pharmacists attitude toward their role as members
of the health care team in reporting ADRs, factors that
encourage or discourage ADR reporting and their behavior
in relation to ADRs.
Pharmacist’s role in pharmacovigilance may vary from
country to country. (Grootheest et al., 2004) Studies assessing
the knowledge, attitude and behavior of pharmacists in ADR
related aspects have been reported in various countries, includ-
ing in Middle East and North Africa regions (MENA) Ting
et al., 2010; Zolezzi and Parsotam, 2005; Elkami et al., 2011;
Grootheest et al., 2004; Mes et al., 2002; Toklu and Uysal,
2004; Green et al., 1999; Herderiro et al., 2006; Rouleau
et al., 2011; Gavaza et al., 2011; Bawazir, 2006; Vessal et al.,
2009. Various levels of the knowledge of community pharma-
cists in pharmacovigilance have been reported in various coun-
tries as well as various factors inﬂuencing their involvement
(Grootheest et al., 2004).
Oman has a pharmacovigilance program functioning under
the auspices of the Drug Control Department, Directorate
General of Pharmacy Affairs and Drugs Control, Sultanate
of Oman. (Adverse drug reaction reporting in Oman, 2012)All the health care professionals are expected to report ADRs
to the center as part of the pharmacovigilance program. The
directorate carries out active training programs for the health
care professionals including community pharmacists on phar-
macovigilance. According to the statistics of 2012 of the Drug
Control Department of Oman, there are 1200 registered phar-
macists working in the community sector in 476 establish-
ments. Pharmacist’s perception of their role with regard to
ADR reporting and related activities can greatly inﬂuence their
contribution and the same needs to be evaluated. Pharmacists
as drug experts are expected to have good knowledge regard-
ing the safety related aspects of drugs and it would be ideal
to know their knowledge on drug safety as representative
information. There are no published studies from Oman which
tried to evaluate these important aspects. Hence, this pilot
study was conducted with the aim of assessing the knowledge,
attitude and behavior of community pharmacists on ADR re-
lated aspects.
2. Methodology
The study was approved by the Institutional Research Com-
mittee, College of Pharmacy and Nursing, University of Niz-
wa. This was a questionnaire based cross sectional survey
conducted as a pilot study. A self administered questionnaire
was designed based on the parameters to be evaluated as part
of the study and by referring to previous literature. (Ting et al.,
2010; Mes et al., 2002; Herderiro et al., 2006; Rouleau et al.,
2011; Bawazir, 2006). Questionnaire had mainly three sections
totally comprising of 21 questions. Section 1 comprised of 9
questions to assess the knowledge of pharmacists on some of
selected basic aspects of drug safety. These questions were a
mix of general and sometimes speciﬁc safety information on
certain drugs or reactions. The purpose of these questions
was to have a general assessment of the knowledge on safety
related aspects that pharmacists might come across during rou-
tine practice. Section 2 had questions to assess the knowledge
(n= 3), and attitude (n= 3) of community pharmacists to-
ward ADR reporting and to assess their behavior (n= 4) on
ADR related aspects. The responses to the questions in this
section were supposed to be marked in a ﬁve point likert scale
ranging from strongly agree to strongly disagree. Section 3 was
to capture demographic and professional details of the
respondents.
The actual survey was conducted during a 2-month period
between April–June 2012 among qualiﬁed pharmacists in
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tive governorates among the ten governorates in Oman. All
the community pharmacists in one wilayat (Wilayat of Sur)
of the South Sharqiya Governorate and 2 wilayats of the Mus-
cat governorate (Wilayat of Boushar and Al-Qurum) were ap-
proached for the study purpose. Those pharmacists who were
willing to participate in the study were provided the prepared
study information sheet (which explained the purpose of the
study and study procedure) and were requested to sign the in-
formed consent form. Enrolled participants were provided the
questionnaire to respond.
The data from the ﬁlled questionnaires were evaluated for
various parameters. The responses of questions in Section 1
were assessed by estimating the percentage of respondents pro-
viding the correct answer to each question. A scoring scheme
was followed with a score of 1 for a correct response and 0
for incorrect response. Accordingly, the total score of the indi-
vidual participants for section 1 (Q1–9) was estimated and the
median total score was estimated.
The questions in Section 2 related to knowledge, attitude
and behavior were assessed using a scoring scheme with a score
of 5, 4, 3, 2, and 1 for respective responses ranging from most
appropriate to most inappropriate response. Accordingly, the
median knowledge, attitude and behavior score of the respon-
dents was estimated. The maximum possible score of knowl-
edge, attitude and behavior was 15, 15 and 20 respectively
and a minimum score of zero for all the categories. Addition-
ally, the median total score based on responses to all the as-
pects; knowledge, attitude and behavior was estimated with a
maximum possible score of 50 and a minimum score of 0. A
score equal to and greater than 80% of the possible maximum
score was considered as good, between 60% and 79% as mod-
erate and less than 60% as poor for quantitative representation.
Difference in the median score obtained for Sections 1 and 2
were estimated based on gender, age group, educational quali-
ﬁcation and status of receiving training on pharmacovigilance.
The results were statistically analyzed using SPSS (version
15) where the Mann–Whitney U test and the Kruskal WallisTable 1 Demographics of respondents and relationship between th
Demographics No. (%) Median total score (IQR) Q 1–9
Gender
Male 68 (63.6) 5 (2)
Female 39 (36.4) 4 (2)
Age group (yrs)
18-30 54 (50.5) 5 (2)
31- 45 47 (43.9) 5 (3)
46-60 6 (5.6) 6 (2.25)
Qualiﬁcation
D.Pharm 27 (25.2) 4 (1)
B.Pharm 75 (70.1) 5 (3)
M.Pharm 5 (4.7) 6 (1.5)
Years of experience
<1 5 (4.7) 4 (0.5)
1–2 10 (9.3) 4 (1.5)
>2–5 39 (36.4) 5 (2)
>5–10 28 (26.1) 5 (3)
>10 25 (23.4) 6 (2.5)
Training received in pharmacovigilance
Yes 35 (32.7) 5 (3)
No 72 (67.3) 5 (2)test was used for continuous variables for non parametric data
depending on the number of comparative groups and for para-
metric data independent Sample ‘t’ test was used. The p value
of <0.05 was considered to be statistically signiﬁcant.
3. Results
One hundred and seven questionnaires were obtained from the
distributed 148 questionnaires giving a response rate of 72.3%.
Characteristics of the respondents are represented in Table 1.
Comparatively, there was a higher percentage of males and
those in the age group of 18–30. Vast majority of the respon-
dents had a bachelor’s degree in pharmacy and only 32% of
them had received training in pharmacovigilance.
3.1. Knowledge on basic aspects on drug safety in routine
practice (Section 1)
The responses to questions in Section 1 assessing the basic as-
pects on drug safety in routine practice are tabulated in Ta-
ble 2. Even though the majority of the respondents gave a
correct response to most of the questions, at many instances,
a good number gave incorrect responses to questions which
are expected to be known by community pharmacists on a dai-
ly basis. Consequently, the total median score for the questions
in Section 1 was 5 (Inter quartile range IQR, 2) out of a pos-
sible maximum score of 9 which was a poor score.
3.2. Responses to knowledge, attitude and behavior related
questions
Community pharmacist’s responses to questions related to
knowledge, attitude and behavior on ADR reporting and on
ADR related aspects are represented in Table 3. The median
score for knowledge related questions was 10 (IQR 4) out of
a maximum possible score of 15 which demonstrates a moder-
ate knowledge score. Around 89% of the participants wase median total score.
p value Median total score (IQR) Q 10–19 p value
0.303 39 (8.75)
38 (9) 0.501
0.309 39 (8.5)
38 (7) 0.451
45 (10)
0.010 38 (9) 0.695
38 (8)
44 (9)
0.024 48(11.5) 0.671
37 .5 (11.5)
38 (8)
40.5 (10)
38 (8.5)
0.342 44 (5) 0.000
38 (6)
Table 2 Responses to questions related to ADRs (Q 1–9).
Questions Correct response no.
(%)
Incorrect response no.
(%)
1-What is an adverse drug reaction (ADR)?
(a) Harmful effects which occur when a drug is used in the usual dose
(b) Only allergic/hypersensitivity responses to drugs
(c) Effects occurring only when drugs are taken in excess dose
(d) None of the above
42 (84%) 8 (16%)
2-Which among the statement regarding ADRs is correct?
(a) ADRs are always preventable
(b) ADRs are preventable to some extent
(c) ADRs are not predictable at all
(d) ADRs refer only to the serious harmful effects of drugs
24 (48%) 26 (52%)
3-The most common ADR with anti tubercular drugs includes
(a) Alopecia
(b) Hepatotoxicity
(c) Skin rashes
(d) Renal toxicity
28 (56%) 22 (44%)
4-Which among the following drugs is most unsafe in a pregnant patient?
(a) Erythromycin
(b) Paracetamol
(c) Amlodipine
(d) Ciproﬂoxacin
31 (62%) 19 (38%)
5-Side eﬀects which can occur more commonly while administering inhaled salbutamol include
(a) Oral fungal infection
(b) Palpitation
(c) Change in voice
(d) Oral bleeding
32 (64%) 18 (36%)
6-Gingival hyperplasia is more commonly seen with
(a) Enalapril
(b) Ciproﬂoxacin
(c) Amlodipine
(d) Losartan
34 (68%) 16 (32%)
7-Metallic taste is most commonly caused by
(a) Glibenclamide
(b) Furosemide
(c) Metronidazole
(d) Ampicillin
39 (78%) 11 (22%)
8-Dry cough with enalapril is more likely to occur in
(a) Elderly
(b) Pediatrics
(c) Males
(d) Females
10 (20%) 40 (80%)
9-NSAID induced ulcer is most likely to occur in
(a) Elderly
(b) Those who are taking steroids with NSAIDs
(c) Alcoholics
(d) All of above
32 (64%) 18 (36%)
166 J. Jose et al.aware of the National Pharmacovigilance program (ADR
reporting program) in Oman. Twenty percentage thought that
only ADRs to new drugs need to be reported to the regulatory
agency or Drug Company. The median attitude score was 12(IQR 2) demonstrating a fairly good attitude of the community
pharmacists toward ADR reporting and related activities.
Majority (90.6%) of the participants considered reporting of
ADRs as a professional responsibility of the pharmacists.
Table 3 Responses to knowledge, attitude and behavior related questions.
Questions Agree (%) Neutral (%) Disagree (%)
Awareness of the National Pharmacovigilance Program in Oman 95 (88.8) 10 (9.3) 2 (1.9)
Only ADRs to new drugs to be reported to the regulatory agency or drug company 22 (20.5) 21 (19.6) 64 (59.8)
ADRs observed to topical agents need not be reported to the regulatory agency or drug company 45 (42) 10 (9.3) 52 (48.6)
Reporting of ADRs adds up to existing knowledge of ADRs to old and new drugs 93 (86.9) 9 (8.4) 5 (4.7)
Reporting of ADRs is a professional responsibility of the pharmacists 97 (90.6) 9 (8.4) 1 (0.9)
Reporting of ADRs adds up to unnecessary workload 12 (11.2) 27 (25.2) 68 (63.6)
Report ADRs to the regulatory agency in Oman/drug company 74 (69.2) 25 (23.4) 8 (7.4)
Ask for the allergy history of the patient before dispensing the medication 89 (83.2) 18 (16.8) 0 (0)
Inform the patient of the important side eﬀects of the medications 98 (91.5) 7 (6.5) 2 (1.9)
Inform patients of the methods to prevent ADRs of the dispensed medications 93 (86.9) 12 (11.2) 2 (1.9)
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with a median score of 16 (IQR 3) out of a maximum possible
score of 20. Eighty-three percent of the participants reported
asking for the allergy history in the patients before dispensing
the medication, where ever required. Total median score based
on knowledge, attitude and behavior was 38 (IQR 8) out of a
possible maximum score of 50 which demonstrates a moderate
score. Many factors discouraged reporting of ADRs by the
pharmacists with the major share being lack of awareness on
how to report ADR, concern that the report may be wrong,
concern that the prescriber may be concerned with pharmacist
reporting and non-remuneration for reporting.
3.3. Relating the median score with the participant
characteristics
The knowledge of the participants on the basic aspects on drug
safety in routine practice (median score for Section 1) differed
signiﬁcantly only based on qualiﬁcation (p= 0.010) and years
of experience (p= 0.024); Table 1. Those pharmacists with a
master’s qualiﬁcation and bachelors were having a better score
compared to those with only a diploma. Similarly, higher the
years of experience, better was their median total score.Table 4 Demographics of respondents and relationship between m
Demographics Median Knowledge Score p value Median A
Gender
Male 10 (3) 0.396 12.5 (2)
Female 10 (4) 12 (3)
Age group
18–30 11 (3.25) 0.339 12 (3)
31–45 10 (3) 12 (2)
46–60 13.5 (5.5) 13 (2.25)
Qualiﬁcation
D.Pharm 10 (4) 0.680 12 (5)
B.Pharm 10 (3) 12 (2)
M.Pharm 13 (5.5) 13 (3.5)
Years of experience
<1 14 (4.5) 15 (4.5)
1-2 10 (6) 0.325 12.5 (2)
>2-5 10 (2) 12 (3)
>5-10 10 (4) 12.5 (3.75
>10 10 (4) 12 (2)
Training received
Yes 12 (5) 0.011 14 (2)
No 10 (3) 12 (2)Apparently, the median total score for Section 2 assessing
the knowledge, attitude and behavior on ADR reporting and
related aspects differed signiﬁcantly only based on the status
of receiving training in pharmacovigilance (p= 0.000); Ta-
ble 1. Similarly, the individual aspects of knowledge, attitude
and behavior did not differ based on the demographics of
the participants while all the individual aspects were signiﬁ-
cantly better for those who have received training in pharma-
covigilance; Table 4.4. Discussion
Knowledge and attitude of pharmacists on drug safety related
aspects could greatly inﬂuence their behavior and thereby con-
tribute to patient safety. It is important to assess these param-
eters to identify the need for actions or interventions from
various bodies including regulatory organisations. The present
study is the ﬁrst study of its kind in Oman which tried to assess
the knowledge, attitude and behavior of community pharma-
cists to ADR related aspects. The present study was designed
as a pilot study before a broader study could be conducted
among a wider population.edian knowledge, attitude and behavior score.
ttitude Score p value Median Behavior Score p value
0.115 16 (4) 0.603
16 (2)
0.709 17 (4) 0.451
16 (3)
17 (2.5)
0.920 16 (3) 0.315
16 (3)
18 (3)
0.769 18(3) 0.861
16 (4.25)
16 (4)
) 16 (3.5)
16 (2)
0.000 17 (3) 0.002
16 (3)
168 J. Jose et al.Majority of the participants in the study were males and
those with a bachelor’s degree qualiﬁcation. More pharmacists
who were young (age group of 18–30) and had lesser years of
experience (>2–5 years) participated in the study. Only just
more than a quarter of the participants had received any sort
of training in ADR reporting in the past.
Total median score based on questions related to ADRs in
general and for some speciﬁc ADRs/drugs was poor. It was
discouraging to note that a good majority of the participants
gave an incorrect response to questions related to daily prac-
tice such as palpitation as a common side effect of inhaled sal-
butamol and risk factors for NSAID induced ulcers.
Qualiﬁcation as well as years of experience had a signiﬁcant
inﬂuence on the knowledge of pharmacists on ADR related as-
pects useful on a daily basis. This is a ﬁnding which is self
explanatory. We could not ﬁnd published studies evaluating
the knowledge of pharmacists speciﬁcally to certain drugs or
reactions to make effective comparisons for these results.
A moderate knowledge of community pharmacists toward
ADR reporting as evident from the median knowledge score
was observed. Almost all of them were aware of the National
Pharmacovigilance program in Oman which is a good indica-
tor of the effectiveness of the activities carried out by regula-
tory agencies in Oman in raising awareness on ADR
reporting. This was different from the results obtained in the
study conducted among community pharmacists in Turkey,
where only (17.2%) of the pharmacists had any knowledge
about pharmacovigilance (Toklu and Uysal, 2004).
Total median attitude score demonstrated a good level of
attitude of pharmacists toward ADR related activities. It was
encouraging to note that almost all of them were in agreement
that reporting of ADR helps in adding up to existing knowl-
edge on ADR to old and new drugs and the majority of the
participants considered reporting of ADRs as a professional
responsibility of the pharmacists. This was similar with the
study conducted in Saudi Arabia (Bawazir, 2006) where 97%
of them considered reporting of ADRs to be an integral part
of pharmaceutical care and in Turkey (Toklu and Uysal,
2004) where 89% of the pharmacists believed that the role of
the pharmacist in ADR reporting was essential.
Participants reported good behavior on ADR reporting
and related aspects. Around 70% of the participants claimed
that they report ADRs to the regulatory agency in Oman or
to the Drug Company. Most of the participants rarely (82%)
observe or have patients report ADRs to them. In the study
conducted in Turkey, 65% of the pharmacists stated that the
patients reported an ADR to them during the previous
12 months and 21% of the pharmacists reported to the con-
cerned organizations. (Toklu and Uysal, 2004) It was encour-
aging to note that community pharmacists reported asking for
allergy history before dispensing medicines and informing pa-
tients of important side effects and methods to prevent ADRs.
Several factors were identiﬁed by the community pharma-
cist which discourage them from reporting of ADRs; lack of
awareness on how to report ADRs and concern that the report
may be wrong as the commonest factors. These factors have to
be addressed and effectively solved during the educational/
awareness programs conducted for the pharmacists. Similarly
in the study conducted among community pharmacists in Can-
ada and Saudi Arabia, several barriers were identiﬁed that pre-
vent pharmacists from reporting ADR including, unknown
address, reporting form not available, do not know how toreport (41.7%) and uncertainty concerning causal relationship
between ADR and the drug (30.1%) (Rouleau et al., 2011;
Bawazir, 2006).
No signiﬁcant difference in total median score for questions
on knowledge, attitude and behavior on ADR related aspects
in relation with the participant demographics was observed
similar to the study conducted in Malaysia (Elkami et al.,
2011). But, the same differed depending on the status of train-
ing on pharmacovigilance received in the past. This indicates
the inﬂuence and need of extensive efforts from regulatory
bodies at a larger scale to improve and maintain the knowledge
and attitude of community pharmacists on ADR reporting
and related aspects.
Our study did have some limitations. As the number of par-
ticipants was limited being a pilot study, we could not general-
ize the results to the entire community pharmacy population in
the country. Behavior score obtained was based on what the
participants claim to be doing, which may be different from
what might be happening in the actual situation.
5. Conclusion
In conclusion, the majority of community pharmacists had
below than acceptable knowledge on drug safety related as-
pects on speciﬁc drugs and a good number of them were
not aware of certain practical aspects which they are expected
to be aware of. There is a genuine need to have training pro-
grams to improve the knowledge of pharmacists on ADR re-
lated aspects which are of beneﬁt on a daily basis which
could greatly inﬂuence the impact on patient safety. Commu-
nity pharmacist’s knowledge toward ADR reporting was
encouraging even though it requires improvement. A positive
attitude and behavior of community pharmacists toward
ADR reporting and drug safety related aspects were ob-
served. Background training in pharmacovigilance did have
an inﬂuence on the knowledge, attitude and behavior ob-
served. Educational programs have to be continued to gener-
ate awareness on how to report ADR and stimulate
pharmacists’ active participation in the ADR reporting pro-
gram. An extensive study covering all the governorates in
the country is essential to generate more valuable data which
would form the basis for educational interventions and other
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